Search Results - "Therriault, Joseph"
-
1
Microglial activation and tau propagate jointly across Braak stages
Published in Nature medicine (01-09-2021)“…Compelling experimental evidence suggests that microglial activation is involved in the spread of tau tangles over the neocortex in Alzheimer’s disease (AD)…”
Get full text
Journal Article -
2
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages
Published in Brain (London, England : 1878) (16-12-2021)“…Tracking longitudinal tau tangles accumulation across the Alzheimer's disease continuum is crucial to better understand the natural history of tau pathology…”
Get full text
Journal Article -
3
Aβ-induced vulnerability propagates via the brain’s default mode network
Published in Nature communications (04-06-2019)“…The link between brain amyloid-β (Aβ), metabolism, and dementia symptoms remains a pressing question in Alzheimer’s disease. Here, using positron emission…”
Get full text
Journal Article -
4
In vivo quantification of neurofibrillary tangles with [ 18 F]MK-6240
Published in Alzheimer's research & therapy (31-07-2018)“…Imaging agents capable of quantifying the brain's tau aggregates will allow a more precise staging of Alzheimer's disease (AD). The aim of the present study…”
Get full text
Journal Article -
5
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease
Published in EBioMedicine (01-02-2022)“…Phosphorylated tau (p-tau) epitopes in cerebrospinal fluid (CSF) are accurate biomarkers for a pathological and clinical diagnosis of Alzheimer's disease (AD)…”
Get full text
Journal Article -
6
Biomarker modeling of Alzheimer's disease using PET-based Braak staging
Published in Nature aging (01-06-2022)“…Gold-standard diagnosis of Alzheimer's disease (AD) relies on histopathological staging systems. Using the topographical information from [ F]MK6240 tau…”
Get full text
Journal Article -
7
Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease
Published in Molecular psychiatry (01-10-2021)“…Neurofilament light chain (NFL) measurement has been gaining strong support as a clinically useful neuronal injury biomarker for various neurodegenerative…”
Get full text
Journal Article -
8
Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease
Published in Molecular neurodegeneration (26-04-2021)“…Mitochondrial electron transport chain abnormalities have been reported in postmortem pathological specimens of Alzheimer's disease (AD). However, it remains…”
Get full text
Journal Article -
9
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Published in Nature communications (01-10-2024)“…Positron Emission Tomography (PET) ligands have advanced Alzheimer’s disease (AD) diagnosis and treatment. Using autoradiography and cryo-EM, we identify AD…”
Get full text
Journal Article -
10
[11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
Published in Nature communications (19-07-2022)“…Alzheimer’s disease (AD) is characterized by the brain accumulation of amyloid-β and tau proteins. A growing body of literature suggests that epigenetic…”
Get full text
Journal Article -
11
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings
Published in Nature communications (14-03-2024)“…Blood-based biomarkers for screening may guide tau positrion emissition tomography (PET) scan referrals to optimize prognostic evaluation in Alzheimer’s…”
Get full text
Journal Article -
12
Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease
Published in Nature communications (12-06-2024)“…Alzheimer’s disease (AD) is a brain network disorder where pathological proteins accumulate through networks and drive cognitive decline. Yet, the role of…”
Get full text
Journal Article -
13
Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease
Published in Alzheimer's research & therapy (16-08-2018)“…There is accumulating evidence that synaptic loss precedes neuronal loss and correlates best with impaired memory formation in Alzheimer's disease (AD)…”
Get full text
Journal Article -
14
Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer’s disease
Published in European journal of neurology (01-05-2022)“…Background and purpose Abnormal mitochondrial metabolism has been described in the Alzheimer's disease (AD) brain. However, the relationship between AD…”
Get full text
Journal Article -
15
Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer's disease
Published in Journal of integrative neuroscience (30-12-2021)“…Cerebrospinal fluid neurofilament light and plasma neurofilament light concentrations are elevated in patients with mild cognitive impairment and Alzheimer's…”
Get full text
Journal Article -
16
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET
Published in EBioMedicine (01-02-2022)“…Tau in Alzheimer's disease (AD) is assessed via cerebrospinal fluid (CSF) and Positron emission tomography (PET). Novel methods to detect phosphorylated tau…”
Get full text
Journal Article -
17
Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's disease
Published in Alzheimer's research & therapy (29-03-2021)“…To investigate the association of plasma pTau181, assessed with a new immunoassay, with neurodegeneration of white matter and gray matter cross-sectionally and…”
Get full text
Journal Article -
18
The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer's Disease
Published in Frontiers in aging neuroscience (27-04-2021)“…Cerebrospinal fluid (CSF) measurements of neurogranin (Ng) have emerged as a promising biomarker for cognitive decline in mild cognitive impairment (MCI) and…”
Get full text
Journal Article -
19
Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
Published in Nature communications (03-10-2022)Get full text
Journal Article -
20
In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer's disease
Published in Frontiers in aging neuroscience (19-06-2024)“…The molecular mechanisms underlying neuronal dysfunction in Alzheimer's disease (AD) remain uncharacterized. Here, we identify genes, molecular pathways and…”
Get full text
Journal Article